These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32555446)

  • 1. Overview of therapeutic drug research for COVID-19 in China.
    Li H; Yang L; Liu FF; Ma XN; He PL; Tang W; Tong XK; Zuo JP
    Acta Pharmacol Sin; 2020 Sep; 41(9):1133-1140. PubMed ID: 32555446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.
    Liu T; Luo S; Libby P; Shi GP
    Pharmacol Ther; 2020 Sep; 213():107587. PubMed ID: 32470470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
    Magro G
    Travel Med Infect Dis; 2020; 37():101685. PubMed ID: 32334088
    [No Abstract]   [Full Text] [Related]  

  • 4. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering drugs to treat coronavirus disease 2019 (COVID-19).
    Dong L; Hu S; Gao J
    Drug Discov Ther; 2020; 14(1):58-60. PubMed ID: 32147628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
    Wang D; Li Z; Liu Y
    J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment of coronavirus disease 2019 (COVID-19) in China.
    Jin Z; Liu JY; Feng R; Ji L; Jin ZL; Li HB
    Eur J Pharmacol; 2020 Sep; 883():173326. PubMed ID: 32598953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
    Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
    mBio; 2020 May; 11(3):. PubMed ID: 32444382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current pharmacological treatments for SARS-COV-2: A narrative review.
    Nittari G; Pallotta G; Amenta F; Tayebati SK
    Eur J Pharmacol; 2020 Sep; 882():173328. PubMed ID: 32603692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances of therapeutic targets and potential drugs of COVID-19.
    Zhang W; Zhang P; Wang G; Cheng W; Chen J; Zhang X
    Pharmazie; 2020 May; 75(5):161-163. PubMed ID: 32393419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for COVID-19: The reality and challenges.
    Jean SS; Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):436-443. PubMed ID: 32307245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Of chloroquine and COVID-19.
    Touret F; de Lamballerie X
    Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
    Pang X; Cui Y; Zhu Y
    Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
    [No Abstract]   [Full Text] [Related]  

  • 15. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.
    Yang Y; Islam MS; Wang J; Li Y; Chen X
    Int J Biol Sci; 2020; 16(10):1708-1717. PubMed ID: 32226288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal plants coordinate COVID-19 in multiple dimensions - An insight analysis for clinically applied remedies.
    Zhang Y; Li Y; Wang X; Qu R; Li J; Li T; He T; Wang Z; Liu Y; Shao X; Lu T
    Int J Med Sci; 2020; 17(18):3125-3145. PubMed ID: 33173434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2
    Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19 and drug therapy, what we learned.
    Provenzani A; Polidori P
    Int J Clin Pharm; 2020 Jun; 42(3):833-836. PubMed ID: 32382873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.